Herbert Smith Freehills Kramer advises Meiban Group on the acquisition of Planet Innovation

Herbert Smith Freehills Kramer (HSF Kramer) has advised Meiban Group (Meiban) on its acquisition of Planet Innovation by way of scheme of arrangement.

Meiban is a global contract development and manufacturing organisation offering a comprehensive range of product development and advanced manufacturing capabilities. Meiban has global operations throughout Asia, the United States, Europe and Australia with facilities across Singapore and Malaysia, specialising in high-volume, precision manufacturing for the medtech sector. 

Founded in Melbourne, Planet Innovation is a medtech product development company, partnering with medtech companies globally to design, develop and manufacture regulated medical devices in its facilities in Australia and the United States.

The transaction follows a strategic alliance announced by the companies in 2025, where Meiban acquired an initial ~19.9% stake in Planet Innovation. The transaction will enable the two parties to combine their complementary businesses into an integrated contract development and manufacturing organisation serving the global medtech sector.

The HSF Kramer team was led by partner Jason Jordan and senior associate Damien Devnarain, with support from solicitors Sandra Nguyen and Rosalind Wei.

Jason said, “It was a pleasure to work with the Meiban team on this transaction, supporting its entry into the Australian market and its broader vision to improve lives through the products both organisations help bring to market.”

This transaction is another example of HSF Kramer’s market-leading work in M&A. Other recent examples include advising:

• FleetPartners on its proposed acquisition by SG Fleet for $1.13 billion 
• Reliance Worldwide Corporation on its $3.6 billion proposed acquisition by Brookfield
• Ramsay Health Care on its proposal to separate from Ramsay Générale de Santé by in specie distribution under a scheme of arrangement
• Black Kite Partners on the successful completion of its acquisition of 13SICK, DoctorDoctor, 24-7Medcare and Australian Surgical Assisting
• Energy Fuels on its proposed scrip for scrip acquisition of Australian Strategic Materials by scheme of arrangement
• Maas Group Holdings on its proposed sale of its Construction Materials business to Heidelberg Materials for $1.7 billion
• Equity Trustees on its response to control proposals by TPG and BGH
• GIC on the acquisition in consortium with Brookfield of National Storage REIT
• BlueScope Steel on its response to the unsolicited offer from SGH Limited and Steel Dynamics to acquire BlueScope Steel
• EQT on its acquisition of Orikan
• Ampol on its $1.165 billion acquisition of EG Australia